CITRUCEL

Product NDC: 0135-0089
11-digit product format: 001350089
Labeler code: 0135
Product ID: 0135-0089_4d50ac6b-2405-defb-e063-6394a90aa71c
Type: HUMAN OTC DRUG
Nonproprietary name: methylcellulose
Dosage form: POWDER, FOR SOLUTION
Route: ORAL
Labeler: Haleon US Holdings LLC
Application: M007
Marketing category: OTC MONOGRAPH DRUG
Marketing start: 2010-09-16
Substance: METHYLCELLULOSE (4000 MPA.S)
Active strength: 2 g/19g
NDC exclude flag: No
Listing certified through: 2027-12-31
Current FDA listing: Yes

NDC auxiliary status#

These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.

Current NDC status page 1 of 1 · 1 matching rows.

Dataset, Scope, Product NDC table
Dataset	Scope	Product NDC	Package NDC	Code	Status	Reporting period	Source date
excluded package	package	0135-0089	0135-0089-69	D	Discontinued by firm		2026-10-12

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

Additional Listing Data#

Finished product: Yes
Brand name base: CITRUCEL
Listing expiration: 2027-12-31

Active Ingredients#

Ingredient, Strength table
Ingredient	Strength
METHYLCELLULOSE (4000 MPA.S)	2 g/19g

Harmonized UNII identifiers#

UNII identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
Identifier	FDA.report destination
MRJ667KA5E	Internal UNII lookup

Harmonized RxCUI identifiers#

RxCUI identifiers page 1 of 1 · 2 matching rows.

Identifier, FDA.report destination table
Identifier	FDA.report destination
1868843	Internal RxNorm lookup
1868847	Internal RxNorm lookup

Harmonized SPL set identifiers#

SPL set identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
Identifier	FDA.report destination
9d5f2244-a610-4d45-b6e8-e79bb17a558f	Available on FDA.report

DailyMed Product Concepts#

Product concept, Relation, Version table
Product concept	Relation	Version	Effective
ce6d5c06-3ae0-18a6-d5b3-8cd3cc0f8906	Product name	7	20210625

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Related label table
NDC	Effective	Related label
0135-0089-69	2020-11-17	Drug Facts
0135-0089-71	2020-11-17	Drug Facts
0135-0089-69	2020-09-27	Drug Facts
0135-0089-71	2020-09-27	Drug Facts
0135-0089-69	2020-09-25	Drug Facts
0135-0089-71	2020-09-25	Drug Facts
0135-0089-69	2020-07-22	Drug Facts
0135-0089-71	2020-07-22	Drug Facts

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDC	Product	Description	Form	Quantity	Strength	SPL version
0135-0089-69	CITRUCEL	454 g in 1 BOTTLE	POWDER, FOR SOLUTION	454		17
0135-0089-71	CITRUCEL	850 g in 1 BOTTLE	POWDER, FOR SOLUTION	850		17

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDC	Billing unit	Product NDC	DailyMed indexing SPL	SPL version	Effective
0135-0089-69	GM - Gram	0135-0089	6ef4886b-287d-4d39-808c-ecab2773aa69	1	2012-07-24
0135-0089-71	GM - Gram	0135-0089	898fbf5c-06a8-4c13-a68e-74a65717444f	1	2012-07-24

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
Ingredient	Type	UNII	DailyMed label	SPL version
METHYLCELLULOSE (4000 MPA.S)	ACTIVE INGREDIENT	MRJ667KA5E	CITRUCEL (METHYLCELLULOSE) POWDER, FOR SOLUTION [GLAXOSMITHKLINE CONSUMER HEALTHCARE LP]	6
METHYLCELLULOSE (4000 MPA.S)	ACTIVE MOIETY	MRJ667KA5E	CITRUCEL (METHYLCELLULOSE) POWDER, FOR SOLUTION [GLAXOSMITHKLINE CONSUMER HEALTHCARE LP]	6
ASPARTAME	INACTIVE INGREDIENT	Z0H242BBR1	CITRUCEL (METHYLCELLULOSE) POWDER, FOR SOLUTION [GLAXOSMITHKLINE CONSUMER HEALTHCARE LP]	6
CALCIUM PHOSPHATE, DIBASIC, ANHYDROUS	INACTIVE INGREDIENT	L11K75P92J	CITRUCEL (METHYLCELLULOSE) POWDER, FOR SOLUTION [GLAXOSMITHKLINE CONSUMER HEALTHCARE LP]	6
CITRIC ACID MONOHYDRATE	INACTIVE INGREDIENT	2968PHW8QP	CITRUCEL (METHYLCELLULOSE) POWDER, FOR SOLUTION [GLAXOSMITHKLINE CONSUMER HEALTHCARE LP]	6
FD&C YELLOW NO. 6	INACTIVE INGREDIENT	H77VEI93A8	CITRUCEL (METHYLCELLULOSE) POWDER, FOR SOLUTION [GLAXOSMITHKLINE CONSUMER HEALTHCARE LP]	6
MALIC ACID	INACTIVE INGREDIENT	817L1N4CKP	CITRUCEL (METHYLCELLULOSE) POWDER, FOR SOLUTION [GLAXOSMITHKLINE CONSUMER HEALTHCARE LP]	6
MALTODEXTRIN	INACTIVE INGREDIENT	7CVR7L4A2D	CITRUCEL (METHYLCELLULOSE) POWDER, FOR SOLUTION [GLAXOSMITHKLINE CONSUMER HEALTHCARE LP]	6
POTASSIUM CITRATE	INACTIVE INGREDIENT	EE90ONI6FF	CITRUCEL (METHYLCELLULOSE) POWDER, FOR SOLUTION [GLAXOSMITHKLINE CONSUMER HEALTHCARE LP]	6
RIBOFLAVIN	INACTIVE INGREDIENT	TLM2976OFR	CITRUCEL (METHYLCELLULOSE) POWDER, FOR SOLUTION [GLAXOSMITHKLINE CONSUMER HEALTHCARE LP]	6
SUCROSE	INACTIVE INGREDIENT	C151H8M554	CITRUCEL (METHYLCELLULOSE) POWDER, FOR SOLUTION [GLAXOSMITHKLINE CONSUMER HEALTHCARE LP]	6
TITANIUM DIOXIDE	INACTIVE INGREDIENT	15FIX9V2JP	CITRUCEL (METHYLCELLULOSE) POWDER, FOR SOLUTION [GLAXOSMITHKLINE CONSUMER HEALTHCARE LP]	6
TRICALCIUM PHOSPHATE	INACTIVE INGREDIENT	K4C08XP666	CITRUCEL (METHYLCELLULOSE) POWDER, FOR SOLUTION [GLAXOSMITHKLINE CONSUMER HEALTHCARE LP]	6

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDC	Dashboard title	SPL version	Validation	Dashboard ZIP
0135-0089	CITRUCEL (METHYLCELLULOSE) POWDER, FOR SOLUTION [HALEON US HOLDINGS LLC]	16	Current NDC, Legacy NDC, 2 package rows	20240612_9d5f2244-a610-4d45-b6e8-e79bb17a558f.zip

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 9 of 42 · 833 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
Stool Softener plus Stimulant Laxative	DOCUSATE SODIUM 50 MG AND SENNOSIDES 8.6 MG	CARDINAL HEALTH, 110 DBA LEADER	3fd9ba76-42f8-4ebe-b1bc-f81f08e702ce	2026-03-06	Warnings	Exact identifier application number: M007
Magnesium Citrate	EQUATE MAGNESIUM CITRATE ORAL SOLUTION - LEMON	Walmart Inc.	484d0421-59ea-3783-e063-6394a90af633	2026-03-04	Warnings	Exact identifier application number: M007
Magnesium Citrate	EQUATE MAGNESIUM CITRATE ORAL SOLUTION - CHERRY	Walmart Inc.	484c2586-9e6f-1ce5-e063-6394a90a0d81	2026-03-04	Warnings	Exact identifier application number: M007
Magnesium Citrate	EQUATE MAGNESIUM CITRATE ORAL SOLUTION - GRAPE	Walmart Inc.	450ddcbd-7ccd-3670-e063-6294a90ac2bd	2026-03-04	Warnings	Exact identifier application number: M007
Epsom Salt	MAGNESIUM SULFATE	Amazon.com Services LLC	787ec4b0-c6c5-44ab-a53d-d6d25304f95e	2026-03-03	Warnings, Adverse reactions	Exact identifier application number: M007
citroma	MAGNESIUM CITRATE	Old East Main Co.	3d0d63d7-640d-4e54-a6fd-6b265c79be09	2026-03-02	Warnings, Adverse reactions	Exact identifier application number: M007
citroma	MAGNESIUM CITRATE	Old East Main Co.	9b3b6cea-ab83-4b7c-a425-fd0ac7df426c	2026-03-02	Warnings, Adverse reactions	Exact identifier application number: M007
citroma	MAGNESIUM CITRATE	Old East Main Co.	51ed515b-cc51-4ea1-b612-090476135005	2026-03-02	Warnings, Adverse reactions	Exact identifier application number: M007
Epsom Salt	MAGNESIUM SULFATE	Old East Main Co.	a8af6e2d-0052-4fc9-a51a-c9dbeb1ad3f5	2026-03-02	Warnings, Adverse reactions	Exact identifier application number: M007
citroma	MAGNESIUM CITRATE	Chain Drug Marketing Association	629c5817-13b7-4527-8998-93131ee3529e	2026-02-27	Warnings, Adverse reactions	Exact identifier application number: M007
citroma	MAGNESIUM CITRATE	Chain Drug Marketing Association	4df97cdc-e7a2-4350-8f95-a679cdcaff64	2026-02-27	Warnings, Adverse reactions	Exact identifier application number: M007
citroma	MAGNESIUM CITRATE	Chain Drug Marketing Association	46b26b44-e065-4337-a071-fa036f897140	2026-02-27	Warnings, Adverse reactions	Exact identifier application number: M007
Magnesium Citrate	MAGNESIUM CITRATE	Chain Drug Marketing Association	ef163b24-ce92-4cbc-b45a-4fae3b511949	2026-02-27	Warnings, Adverse reactions	Exact identifier application number: M007
Epsom Salt	MAGNESIUM SULFATE	Chain Drug Marketing Association	4ee26633-8eb1-4c68-a768-20460404533a	2026-02-27	Warnings, Adverse reactions	Exact identifier application number: M007
Mineral Oil	MINERAL OIL	Chain Drug Marketing Association	3bfdad9c-ac58-4e92-b952-555e8a8351cd	2026-02-27	Warnings, Adverse reactions	Exact identifier application number: M007
Magnesium Citrate	MAGNESIUM CITRATE	The Kroger Co.	2bcab227-42b6-4bff-8363-f6800665755b	2026-02-27	Warnings, Adverse reactions	Exact identifier application number: M007
Magnesium Citrate	MAGNESIUM CITRATE	The Kroger Co.	a87dceb2-da73-4d3a-b87c-db2af10471bf	2026-02-27	Warnings, Adverse reactions	Exact identifier application number: M007
Sunscreen	AVOBENZONE, HOMOSALATE, OCTISALATE, OCTOCRYLENE	The Kroger Co.	3ae7e275-7bbc-4e62-b30f-013c40a89949	2026-02-27	Warnings	Exact identifier application number: M007
Sennosides	SENNOSIDES	CVS Pharmacy, Inc	0b7736df-c7de-7d00-e063-6294a90aa57e	2026-02-26	Warnings	Exact identifier application number: M007
DOCUSATE SODIUM	DOCUSATE SODIUM	PD-Rx Pharmaceuticals, Inc.	5d300ea7-78eb-4e19-8333-1e42c73c4c54	2026-02-26	Warnings	Exact identifier application number: M007

UNII, Preferred term, Registry number table
UNII	Preferred term	Registry number	Matched term
MRJ667KA5E	METHYLCELLULOSE (4000 MPA.S)	9004-67-5	METHYLCELLULOSE (4000 MPA.S)

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUI	RxNorm string	TTY	DailyMed	SPL version
1868847	CITRUCEL 2 GM Powder for Oral Suspension	PSN	9d5f2244-a610-4d45-b6e8-e79bb17a558f	17
1868843	methylcellulose 2 GM Powder for Oral Suspension	PSN	9d5f2244-a610-4d45-b6e8-e79bb17a558f	17
1868847	methylcellulose 2000 MG Powder for Oral Suspension [Citrucel]	SBD	9d5f2244-a610-4d45-b6e8-e79bb17a558f	17
1868843	methylcellulose 2000 MG Powder for Oral Suspension	SCD	9d5f2244-a610-4d45-b6e8-e79bb17a558f	17
1868847	Citrucel 2 GM Granules for Oral Suspension	SY	9d5f2244-a610-4d45-b6e8-e79bb17a558f	17
1868847	Citrucel 2 GM Powder for Oral Suspension	SY	9d5f2244-a610-4d45-b6e8-e79bb17a558f	17
1868847	Citrucel 2000 MG Powder for Oral Suspension	SY	9d5f2244-a610-4d45-b6e8-e79bb17a558f	17
1868843	methylcellulose 2 GM Granules for Oral Suspension	SY	9d5f2244-a610-4d45-b6e8-e79bb17a558f	17
1868843	methylcellulose 2 GM Powder for Oral Suspension	SY	9d5f2244-a610-4d45-b6e8-e79bb17a558f	17

Packages#

Package NDC, 11-digit format, Description table
Package NDC	11-digit format	Description	Units	Marketing start	Marketing end	Sample	Exclude flag	Status
0135-0089-69	00135008969	454 g in 1 BOTTLE (0135-0089-69)	454 g	2010-09-16	0000-00-00	No	No	Current
0135-0089-71	00135008971	850 g in 1 BOTTLE (0135-0089-71)	850 g	2010-09-16	0000-00-00	No	No	Current